Analyst Price Targets — AXON
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 3, 2026 11:47 am | — | Argus Research | $600.00 | $506.98 | TheFly | Axon price target raised to $600 from $460 at Argus |
| August 6, 2026 3:37 pm | Meta Marshall | Morgan Stanley | $640.00 | $528.41 | TheFly | Axon price target raised to $640 from $600 at Morgan Stanley |
| August 6, 2026 1:32 pm | — | Goldman Sachs | $715.00 | $561.47 | TheFly | Axon price target raised to $715 from $535 at Goldman Sachs |
| August 6, 2026 12:59 pm | — | Piper Sandler | $732.00 | $551.40 | TheFly | Axon price target raised to $732 from $724 at Piper Sandler |
| August 6, 2026 9:08 am | — | Barclays | $688.00 | $609.49 | TheFly | Axon price target raised to $688 from $523 at Barclays |
| July 13, 2026 11:01 am | — | Piper Sandler | $724.00 | $565.80 | TheFly | Axon price target raised to $724 from $674 at Piper Sandler |
| July 6, 2026 11:29 am | — | Needham | $750.00 | $597.04 | StreetInsider | Axon Enterprise (AXON) PT Raised to $750 at NeedhamMember Login |
| June 15, 2026 2:06 pm | James Fish | Piper Sandler | $674.00 | $457.33 | StreetInsider | Piper Sandler Reiterates Overweight Rating on Axon Enterprise (AXON) |
| May 8, 2026 10:10 am | Tim Long | Barclays | $523.00 | $426.89 | TheFly | Axon price target lowered to $523 from $682 at Barclays |
| May 7, 2026 1:15 pm | — | Morgan Stanley | $600.00 | $433.82 | TheFly | Axon price target lowered to $600 from $675 at Morgan Stanley |
Latest News for AXON
On Sept. 1, 2026, rising crude and Treasury yields pressured equities across nearly every sector, with tech stocks bearing the brunt of the selloff.
Shares of Axon Enterprise Inc. (NASDAQ:AXON) are sliding Tuesday afternoon, dropping nearly 8% to hover near $522 after falling over 5% during Monday's session.
Axon's Dedrone C2 upgrades, strategic partnerships and rising CUAS demand are fueling momentum after revenues topped $100 million in Q2 2026.
Bamco Inc. NY acquired a new stake in shares of Axon Enterprise, Inc (NASDAQ: AXON) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 153,615 shares of the biotechnology company's stock, valued at approximately $86,118,000. Bamco Inc. NY owned about 0.19% of
Axon Enterprise currently demonstrates a more consistent pattern of sequential revenue expansion across recent reporting periods, although Booking continuously generates a much larger total volume of absolute sales. Over the last eight quarters, Axon Enterprise recorded steady quarter-over-quarter revenue growth, whereas Booking exhibited a distinct cyclical pattern characterized by recurring peaks and subsequent…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.